The Effect of a Multispecies Probiotics on Autism Symptoms in Children

Recruiting N/A Interventional Study
Autism Spectrum Disorder
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
7 – 15
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
110 (estimated)
Sponsor
Medical University of Warsaw · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In this trial, the investigators aim to evaluate the impact of a multispecies probiotic consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococcus lactis W19, Propionibacterium freudenreichii W200, on the severity of autism symptoms, quality of life, gastrointesti…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of ASD according to the Diagnostic and Statistical Manual of Mental Disorders, the fifth edition (DSM-5) or International Classification of Diseases, Tenth Revision (ICD-10). 2. Children either not taking any medication or receiving the same medication for the last …
Contacts

Maja Kotowska, MD

+48223179536

kotowska.maja@gmail.com

CONTACT

Jan Łukasik, MD, PhD

+48223179536

jan.lukasik@wum.edu.pl

CONTACT